α-Galactose based neoglycopeptides. Inhibition of verotoxin binding to globotriosylceramide

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 12, 1999, Pages 2823-2833

  Arya, Prabhat ^a   Kutterer, Kristina M K ^a   Qin, Huiping ^a   Roby, Johanne ^a   Barnes, Michael L ^a   Lin, Shuqiong ^a   Lingwood, Clifford A ^b   Peter, Markus G ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Carbohydrate protein interactions; Globotriosylceramide mimics; Glycomimetics; Glycopeptides; Neoglycopeptides; Verotoxin

Indexed keywords

GALACTOSE; GLOBOTRIAOSYLCERAMIDE; GLYCOPEPTIDE; NEOGLYCOPEPTIDE; NEOGLYCOPROTEIN; SUGAR; TRISACCHARIDE; UNCLASSIFIED DRUG; VEROTOXIN;

ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY;

ANTI-INFECTIVE AGENTS; BACTERIAL TOXINS; CARBOHYDRATE SEQUENCE; DRUG DESIGN; GALACTOSE; GLYCOPEPTIDES; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; SHIGA-LIKE TOXIN I; STRUCTURE-ACTIVITY RELATIONSHIP; TRIHEXOSYLCERAMIDES;

EID: 0033384170     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00226-6     Document Type: Article

References (31)

1. Varki A. Glycobiology. 3:1993;97.
2. Dwek R.A. Chem. Rev. 96:1996;683.
3. Sears P., Wong C.-H. Proc. Natl. Acad. Sci. USA. 93:1996;12086.
4. Kiessling L.L., Pohl N.L. Chem. Biol. 3:1996;71. and references therein.
5. Lee Y.C., Lee R.T. Acc. Chem. Res. 28:1995;321.
6. Mammen M., Choi S.-K., Whitesides G.M. Angew. Chem. Int. Ed. Engl. 37:1998;2754.
7. McAuliffe, J. C.; Hindsgaul, O. Chem. and Ind. 1998, 170.
8. Roy, R. In Carbohydrates in Drug Design; Witczak, Z. J., Niefort, K. A., Eds; Marcel Dekker, Inc.: New York, 1997; pp 83-135.
9. Lingwood C.A. Trends in Microbiology. 4:1996;147. and references therein.
10. Mortell K.H., Gingras M., Kiessling L.L. J. Am. Chem. Soc. 116:1994;12053.
11. Sigal G.B., Mammen M., Dahmann G., Whitesides G.M. J. Am. Chem. Soc. 118:1996;3789.
12. Spevak W., Nagy J.O., Charych D.H., Schaefer M.E., Gilbert J.H., Bednarski M.D. J. Am. Chem. Soc. 115:1993;1146.
13. Kingery-Wood J.E., Williams K.W., Sigal G.B., Whitesides G.M. J. Am. Chem. Soc. 114:1992;7303.
14. Wang Z.-H.; Hindsgaul, O. In Glycoimmunology 2; Plenum: New York, 1998 and references therein.
15. Wong C.-H., Moris-Varas F., Hung S.-C., Marron T.G., Lin C.-C., Gong K.W., Weitz-Schmidt G. J. Am. Chem. Soc. 119:1997;8152.
16. Hansen H.C., Haataja S., Finne J., Magnusson G. J. Am. Chem. Soc. 119:1997;6974.
17. Siamanek E.E., McGarvey G.J., Jablonoski J.A., Wong C.-H. Chem. Rev. 98:1998;833.
18. Arya P., Dion S., Shimizu G.K.H. Bioorg. Med. Chem. Lett. 7:1997;1537.
19. Arya P., Kutterer K.M.K., Qin H., Roby J., Barnes M.L., Kim J.M., Roy R. Bioorg. Med. Chem. Lett. 8:1998;1127.
20. Jones D.H., Lingwood C.A., Barber K.R., Grant C.W.M. Biochemistry. 36:1997;8539.
21. Lingwood C.A. Glycoconjugate Journal. 13:1996;495.
22. Nyholm P.-G., Magnusson G., Zheng Z., Norel R., Boyd B.B., Lingwood C.A. Chem. Biol. 3:1996;263.
23. Boyd B., Magnusson G., Zhiuyan Z., Lingwood C.A. Eur. J. Biochem. 223:1994;873. and references therein.
24. For a recent example of Gb3 mimics, see: Mylvaganam, M.; Lingwood, C. A. Biochem. Biophys. Res. Commun. 1999, 257, 391.
25. A multivalent form of Gb3 has been found as sub-nanomolar inhibitor for shiga toxins in Bundle's group, unpublished results.
26. Riley L.W., Remis R.S., Helgerson S.D., McGee H.B., Wells J.G., Davis B.R., Hebert R.J., Olcott E.S., Johnson L.M., Hargrett N.T., Blake P.A., Cohen M.C.N. Engl. J. Med. 308:1983;681.
27. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., Lior H. J. Infect. Dis. 151:1985;775.
28. Weinstein D.L., Jackson M.P., Perera L.P., Holmes R.K., O'Brien A.D. Infect. Immun. 57:1989;3743.
29. St. Hilaire P.M., Boyd M.K., Toone E.J. Biochemistry. 33:1994;14452.
30. Ling H., Boodhoo A., Hazes B., Cummings M.D., Armstrong G.D., Brunton J.L., Reed R.J. Biochemistry. 37:1998;1777.
31. Kihlberg J., Elofsson M. Curr. Med. Chem. 4:1997;85-116.